Database of Short Tandem Repeats
| Locus | Repeat type | Motif | Region | Normal | Intermediate | Pathogenic | Inheritance | Disease |
|---|---|---|---|---|---|---|---|---|
| ABCD3 | Standard | GCC | 5′ UTR | – | – | ≥118 | AD | Oculopharyngodistal myopathy (OPDM) |
| AFF2 | Standard | CCG | 5′ UTR | 6-25 | – | ≥200 | XLR | FRAXE mental retardation (FRAXE) |
| AR | Standard | CAG | Coding | 17-35 | – | ≥40 | XLR | Spinal and bulbar muscular atrophy (SBMA) |
| ARX_1 | Imperfect GCN | GCN | Coding | 16 16 | – – | ≥23 ≥18 | XLR XLR | Developmental and epileptic encephalopathy-1 (DEE1) X-linked mental retardation with or without seizures (MRXARX) |
| ARX_2 | Imperfect GCN | GCN | Coding | 12 12 12 | – – – | ≥20 ≥20 ≥23 | XLR XLR XLR | Developmental and epileptic encephalopathy-1 (DEE1) Partington syndrome (PRTS) X-linked mental retardation with or without seizures (MRXARX) |
| ATXN10 | Standard | ATTCT | Intron | 10-29 | 30-799 | ≥800 | AD | Spinocerebellar ataxia 10 (SCA10) |
| ATXN8OS | Standard | CTG | 3′ UTR | 2-37 | 38-79 | ≥80 | AD | Spinocerebellar ataxia 8 (SCA8) |
| ATN1 | Standard | CAG | Coding | 7-23 | – | ≥49 | AD | Dentatorubral-pallidoluysian atrophy (DRPLA) |
| ATXN1 | Standard | CAG | Coding | 6-32 | 36-38 | ≥39 | AD | Spinocerebellar ataxia 1 (SCA1) |
| ATXN2 | Standard | CAG | Coding | 13-31 | 32-34 | ≥35 | AD | Spinocerebellar ataxia 2 (SCA2) |
| ATXN3 | Standard | CAG | Coding | 12-44 | 45-55 | ≥56 | AD | Spinocerebellar ataxia 3 (SCA3) |
| ATXN7 | Standard | CAG | Coding | 4-35 | 28-35 | ≥36 | AD | Spinocerebellar ataxia 7 (SCA7) |
| BEAN1 | Nested | TGGAA | Intron | 0 | – | ≥500 | AD | Spinocerebellar ataxia 31 (SCA31) |
| C9ORF72 | Standard | GGGGCC | Intron | 1-19 | 20-23 | ≥24 | AD | Amyotrophic lateral sclerosis and/or frontotemporal dementia (FTDALS1) |
| CACNA1A | Standard | CAG | Coding | 4-18 | 19 | ≥21 | AD | Spinocerebellar ataxia 6 (SCA6) |
| CBL | Standard | CCG | 5′ UTR | 8-80 | 85-100 | ≥101 | NI | Jacobsen syndrome (JBS) |
| CNBP | Standard | CCTG | Intron | ≤29 | 30-55 | ≥55 | AD | Myotonic dystrophy 2 (DM2) |
| COMP | Standard | GAC | Coding | 5 5 | – – | ≥6 ≥7 | AD AD | Multiple epiphyseal dysplasia (EDM1) Pseudoachondroplasia (PSACH) |
| CSTB | VNTR | CCCCGC... | Promoter | 2-3 | – | ≥30 | AR | Myoclonic epilepsy of Unverricht and Lundborg (ULD) |
| DAB1 | Nested | ATTTC | Intron | 0 | – | ≥31 | AD | Spinocerebellar ataxia 37 (SCA37) |
| DIP2B | Standard | CGG | 5′ UTR | 6-23 | – | ≥273 | AD | Mental retardation, FRA12A type (MRFRA12A) |
| DMD | Standard | GAA | Intron | 11-33 | – | ≥59 | XLR | Duchenne muscular dystrophy (DMD) |
| DMPK | Standard | CTG | 3′ UTR | 5-34 | 35-49 | ≥50 | AD | Myotonic dystrophy 1 (DM1) |
| EIF4A3 | VNTR | TCGGCA... | 5′ UTR | 3-12 | – | ≥15 | AR | Richieri-Costa-Pereira syndrome (RCPS) |
| FGF14 | Standard | GAA | Intron | 8-249 | – | ≥250 | AD | Spinocerebellar ataxia 27B (SCA27B) |
| FMR1 | Standard | CGG | 5′ UTR | 6-40 6-40 | 41-54 41-54 | 55-200 ≥201 | XLD XLD | Fragile X tremor/ataxia syndrome (FXTAS) Fragile X Syndrome (FXS) |
| FOXL2 | Imperfect GCN | GCN | Coding | 14 | – | ≥19 | AD | Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) |
| FXN | Standard | GAA | Intron | 5-30 | – | ≥70 | AR | Friedreich ataxia (FRDA) |
| GIPC1 | Standard | GGC | 5′ UTR | 12-32 | – | ≥73 | AD | Oculopharyngodistal myopathy 2 (OPDM2) |
| GLS | Standard | GCA | 5′ UTR | 5-26 | – | ≥680 | AR | Glutaminase deficiency with impaired intellectual development and progressive ataxia (GD) |
| HOXA13_1 | Imperfect GCN | GCN | Coding | 14 | – | ≥22 | AD | Hand-foot-genital syndrome (HFG) |
| HOXA13_2 | Imperfect GCN | GCN | Coding | 12 | – | ≥18 | AD | Hand-foot-genital syndrome (HFG) |
| HOXA13_3 | Imperfect GCN | GCN | Coding | 18 | – | ≥24 | AD | Hand-foot-genital syndrome (HFG) |
| HOXD13 | Imperfect GCN | GCN | Coding | 15 | – | ≥22 | AD | Synpolydactyly (SPD) |
| HTT | Standard | CAG | Coding | 9-26 | 27-35 | ≥36 | AD | Huntington's disease (HD) |
| JPH3 | Standard | CTG | 3′ UTR | 6-27 | – | ≥41 | AD | Huntington disease-like 2 (HDL2) |
| LRP12 | Standard | CGG | 5′ UTR | 13-45 | – | ≥93 | AD | Oculopharyngodistal myopathy 1 (OPDM1) |
| MARCHF6 | Nested | TTTCA | Intron | 0 | – | ≥668 | AD | Familial adult myoclonic epilepsy 3 (FAME3) |
| NIPA1 | Standard | GCG | 5′ UTR | 6-10 | – | ≥11 | AD | Amyotrophic lateral sclerosis (ALS) |
| NOTCH2NLC | Standard | GGC | 5′ UTR | 7-39 4-41 | – – | ≥90 ≥60 | AD AD | Neuronal intranuclear inclusion disease (NIID) Hereditary essential tremor type 6 (ETM6) |
| NOP56 | Standard | GGCCTG | Intron | 3-14 | – | ≥25 | AD | Spinocerebellar ataxia 36 (SCA36) |
| NUTM2B-AS1 | Standard | CGG | Noncoding transcript | 3-16 | – | ≥700 | AD | Oculopharyngeal myopathy with leukoencephalopathy 1 (OPML1) |
| PABPN1 | Standard | GCG | Coding | 6 | – | ≥7 | AD or AR | Oculopharyngeal muscular dystrophy (OPMD) |
| PHOX2B | Imperfect GCN | GCN | Coding | 20 | – | ≥24 | AD | Central hypoventilation syndrome (CCHS) |
| PPP2R2B | Standard | CAG | 5′ UTR | 7-31 | – | ≥51 | AD | Spinocerebellar ataxia 12 (SCA12) |
| PRNP | VNTR | CCTCAT... | Coding | 5 | – | ≥10 | AD | Creutzfeldt-Jakob Disease (CJD) |
| PRDM12 | Standard | GCC | Coding | ≤14 | – | ≥18 | AR | Hereditary sensory and autonomic neuropathy type VIII (HSAN8) |
| RAPGEF2 | Nested | TTTCA | Intron | 0 | – | ≥60 | AD | Familial adult myoclonic epilepsy 7 (FAME7) |
| RFC1 | Replaced | AAGGG ... | Intron | 0 | – | ≥400 | AR | Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) |
| RILPL1 | Standard | GGC | 5′ UTR | 4-20 | – | ≥135 | AD | Oculopharyngodistal myopathy 4 (OPDM4) |
| RUNX2 | Imperfect GCN | GCN | Coding | 17 | – | ≥20 | AD | Cleidocranial dysplasia (CCD) |
| SAMD12 | Nested | TTTCA | Intron | 0 | – | ≥100 | AD | Familial adult myoclonic epilepsy 1 (FAME1) |
| SOX3 | Imperfect GCN | GCN | Coding | 15 15 | – – | ≥26 ≥22 | XLR XLR | X-linked mental retardation with isolated growth hormone (XLMR) X-linked panhypopituitarism (PHPX) |
| STARD7 | Nested | ATTTC | Intron | 0 | – | ≥274 | AD | Familial adult myoclonic epilepsy 2 (FAME2) |
| TBP | Standard | CAG | Coding | 25-42 | – | ≥43 | AD | Spinocerebellar ataxia 17 (SCA17) |
| TBX1 | Imperfect GCN | GCN | Coding | 15 | – | ≥25 | AD | Tetralogy of Fallot (TOF) |
| TCF4 | Standard | CTG | Intron | ≤31 | – | ≥50 | AD | Fuchs endothelial corneal dystrophy-3 (FECD3) |
| THAP11 | Standard | CAG | Coding | 20-38 | – | ≥47 | AD | Spinocerebellar ataxia (SCA) |
| TNRC6A | Nested | TTTCA | Intron | 0 | – | ≥1100 | AD | Familial adult myoclonic epilepsy 6 (FAME6) |
| VWA1 | VNTR | GGCGCG... | Coding | 2 | – | ≥3 | AR | Hereditary motor neuropathy (HMNR7) |
| XYLT1 | Standard | GGC | 5′ UTR | 9-20 | – | ≥110 | AR | Desbuquois dysplasia-2 (DBQD2) |
| YEATS2 | Nested | TTTCA | Intron | 0 | – | ≥1000 | AD | Familial adult myoclonic epilepsy 4 (FAME4) |
| ZFHX3 | Standard | GGC | Coding | 14-31 | – | ≥42 | AD | Spinocerebellar ataxia 4 (SCA4) |
| ZIC2 | Imperfect GCN | GCN | Coding | 15 | – | ≥25 | AD | Holoprosencephaly 5 (HPE5) |
| ZIC3 | Standard | GCC | Coding | 10 | – | ≥12 | XLR | X-linked VACTERL syndrome (VACTERLX) |